Title
Drugs for Life: How Pharmaceutical Companies Define Our Health (Experimental Futures),Used
Processing time: 1-3 days
US Orders Ships in: 3-5 days
International Orders Ships in: 8-12 days
Return Policy: 15-days return on defective items
Every year the average number of prescriptions purchased by Americans increases, as do healthcare expenditures, which are projected to reach onefifth of the U.S. gross domestic product by 2020. In Drugs for Life, Joseph Dumit considers how our burgeoning consumption of medicine and cost of healthcare not only came to be, but also came to be taken for granted. For several years, Dumit attended pharmaceutical industry conferences; spoke with marketers, researchers, doctors, and patients; and surveyed the industry's literature regarding strategies to expand markets for prescription drugs. He concluded that underlying the continual growth in medications, disease categories, costs, and insecurity is a relatively new perception of ourselves as inherently ill and in need of chronic treatment. This perception is based on clinical trials that we have largely outsourced to pharmaceutical companies. Those companies in turn see clinical trials as investments and measure the value of those investments by the size of the market and profits that they will create. They only ask questions for which the answer is more medicine. Drugs for Life challenges our understanding of health, risks, facts, and clinical trials, the very concepts used by pharmaceutical companies to grow markets to the point where almost no one can imagine a life without prescription drugs.
⚠️ WARNING (California Proposition 65):
This product may contain chemicals known to the State of California to cause cancer, birth defects, or other reproductive harm.
For more information, please visit www.P65Warnings.ca.gov.
- Q: What is the main topic of 'Drugs for Life'? A: The book explores how pharmaceutical companies influence our perception of health and the increasing reliance on prescription medications.
- Q: Who is the author of 'Drugs for Life'? A: The author is Joseph Dumit, who has researched the pharmaceutical industry and its impact on healthcare.
- Q: How many pages does 'Drugs for Life' have? A: The book contains 280 pages.
- Q: What type of binding is used for 'Drugs for Life'? A: The book is available in paperback binding.
- Q: When was 'Drugs for Life' published? A: The book was published on September 3, 2012.
- Q: What condition is the book in? A: The book is listed as 'New' condition.
- Q: What are the key themes discussed in 'Drugs for Life'? A: Key themes include the commercialization of health, the growth of prescription drug markets, and the societal perception of being inherently ill.
- Q: Is 'Drugs for Life' suitable for anyone interested in healthcare? A: Yes, the book is suitable for readers interested in healthcare, pharmaceutical ethics, and medical sociology.
- Q: What insights does the author provide about clinical trials? A: The author provides insights into how clinical trials are conducted and perceived, highlighting their role in expanding drug markets.
- Q: Are there any special features of 'Drugs for Life'? A: The book is noted as a 'Used Book in Good Condition', indicating it may have some wear but is still functional.